Historical record - last NADAC effective date: 7/17/2024
Product Information
BYSTOLIC 5 MG TABLET is a brand product labeled by Allergan, Inc., priced at $5.8440 per EA under NDC 00456140530. Its NADAC has been published 560 times since Nov 28, 2013.
FDA first approved this application on Dec 17, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Allergan, Inc.NDC
00456140530
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
NEBIVOLOL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021742FDA Approved
12/17/2007
TE Code
AB
On Market Since
1/22/2008
Pharmacological Classes
Price Statistics
The NADAC for BYSTOLIC 5 MG TABLET has been published 560 times since Nov 28, 2013, and over the history we have for it it has risen 145.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.8440 per EA |
|---|---|
| All-time high | $5.8478 (Jul 10, 2024) |
| All-time low | $2.3772 (Nov 28, 2013) |
| Median price | $4.5811 |
| Average price | $4.3171 |
| Largest weekly change | +9.5% (Jan 9, 2019) |
| Weeks tracked | 560 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+5.0%
5Y
+15.7%
All
+145.8%
Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
nebivolol hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BYSTOLIC 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BYSTOLIC 5 MG TABLET, manufactured by Allergan, Inc., is $5.8440 per EA (NDC 00456140530), effective Aug 14, 2024.
How has the price of BYSTOLIC 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BYSTOLIC 5 MG TABLET has risen 145.8%. It has been tracked across 560 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BYSTOLIC 5 MG TABLET?
Since Nov 28, 2013, the NADAC for BYSTOLIC 5 MG TABLET has ranged from a low of $2.3772 (Nov 28, 2013) to a high of $5.8478 (Jul 10, 2024), with a median of $4.5811 per EA.
Are there cheaper alternatives to BYSTOLIC 5 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NEBIVOLOL 5 MG TABLET, is $0.1134 per EA — about 98% below BYSTOLIC 5 MG TABLET.
Who manufactures BYSTOLIC 5 MG TABLET?
BYSTOLIC 5 MG TABLET (NDC 00456140530) is labeled by Allergan, Inc., and CMS classifies it as a brand product.